These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3464434)

  • 21. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and karyological analysis of methotrexate-resistant and -sensitive human leukemic CCRF-CEM cells.
    Mini E; Srimatkandada S; Medina WD; Moroson BA; Carman MD; Bertino JR
    Cancer Res; 1985 Jan; 45(1):317-24. PubMed ID: 3855283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
    Miyachi H; Takemura Y; Kobayashi H; Ando Y
    Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperthermia enhances the in vitro activity of 1-hexylcarbamoyl-5-fluorouracil compared to that of 5-fluorouracil.
    Kusumoto T; Maehara Y; Sakaguchi Y; Sugimachi K
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):477-81. PubMed ID: 2703002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of in vivo and in vitro DNA strand breaks from trihalomethane exposure.
    Geter DR; Chang LW; Hanley NM; Ross MK; Pegram RA; DeAngelo AB
    J Carcinog; 2004 Feb; 3(1):2. PubMed ID: 14969591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
    Benz C; Cadman E
    Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT; Cirtain MC; Look AT; Ashmun RA
    Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel pyrrolo[2,3-d]pyrimidine antifolate TNP-351: cytotoxic effect on methotrexate-resistant CCRF-CEM cells and inhibition of transformylases of de novo purine biosynthesis.
    Itoh F; Russello O; Akimoto H; Beardsley GP
    Cancer Chemother Pharmacol; 1994; 34(4):273-9. PubMed ID: 8033293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro.
    Jackson DV; Bender RA
    Cancer Res; 1979 Nov; 39(11):4346-9. PubMed ID: 291476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of CCRF-CEM human leukemic lymphoblasts by triciribine (tricyclic nucleoside, TCN, NSC-154020). Accumulation of drug in cells and comparison of effects on viability, protein synthesis and purine synthesis.
    Moore EC; Hurlbert RB; Massia SP
    Biochem Pharmacol; 1989 Nov; 38(22):4037-44. PubMed ID: 2480791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic synergism of methioninase in combination with 5-fluorouracil and folinic acid.
    Machover D; Zittoun J; Broët P; Metzger G; Orrico M; Goldschmidt E; Schilf A; Tonetti C; Tan Y; Delmas-Marsalet B; Luccioni C; Falissard B; Hoffman RM
    Biochem Pharmacol; 2001 Apr; 61(7):867-76. PubMed ID: 11274973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT; Cirtain MC; Lefko JL
    Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of cytotoxicity by hyperthermia after a long-term culture with 5-fluorouracil in transformed cells.
    Matsuoka H; Sugimachi K; Abe R; Ueo H; Akiyoshi T
    Anticancer Res; 1992; 12(5):1621-5. PubMed ID: 1280030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S; Scher BM; Hellinger N; Scher W
    Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparations.
    Bertrand R; Jolivet J
    J Natl Cancer Inst; 1989 Aug; 81(15):1175-8. PubMed ID: 2787408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of fluoropyrimidine cytotoxicity by methotrexate or 5-methyltetrahydrofolate in human leukemia cells in vitro.
    Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P
    Chemioterapia; 1984 Dec; 3(6):343-9. PubMed ID: 6241507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthermic enhancement of high dose-rate irradiation in 9L gliosarcoma cells.
    Armour EP; Wang Z; Corry PM; Chen PY; Martinez A
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):171-7. PubMed ID: 8270439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic activity of isoliquiritigenin towards CCRF-CEM leukemia cells and its effect on DNA damage.
    Zu Y; Liu X; Fu Y; Shi X; Wu N; Yao L; Efferth T
    Planta Med; 2009 Aug; 75(10):1134-40. PubMed ID: 19291608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
    Takimoto CH; Cadman EC; Armstrong RD
    Mol Pharmacol; 1986 Jun; 29(6):637-42. PubMed ID: 2940459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.